Mécanismes d’action cellulaire des hormones thyroïdiennes
Tài liệu tham khảo
Bianco, 2002, Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases, Endocr Rev, 23, 38, 10.1210/er.23.1.38
Bassett, 2003, Mechanisms of thyroid hormone receptor-specific nuclear and extra nuclear actions, Mol Cell Endocrinol, 213, 1, 10.1016/j.mce.2003.10.033
Flamant, 2003, Thyroid hormone receptors: lessons from knockout and knock-in mutant mice, Trends Endocrinol Metab, 14, 85, 10.1016/S1043-2760(02)00043-7
Brent, 2000, Tissue-specific actions of thyroid hormone: insights from animal models, Rev Endocr Metab Disord, 1, 27, 10.1023/A:1010056202122
Feng, 2000, Thyroid hormone regulation of hepatic genes in vivo detected by complementary DNA microarray, Mol Endocrinol, 14, 947, 10.1210/me.14.7.947
Scanlan, 2004, 3-Iodothyronamine is an endogenous and rapid-acting derivative of thyroid hormone, Nat Med, 10, 638, 10.1038/nm1051
Fazio, 2004, Effects of thyroid hormone on the cardiovascular system, Recent Prog Horm Res, 59, 31, 10.1210/rp.59.1.31
Everts, 1996, Uptake of thyroid hormones in neonatal rat cardiac myocytes, Endocrinology, 137, 4235, 10.1210/en.137.10.4235
Ladenson, 1992, Reversible alterations in myocardial gene expression in a young man with dilated cardiomyopathy and hypothyroidism, Proc Natl Acad Sci USA, 89, 5251, 10.1073/pnas.89.12.5251
Carr, 2002, Thyroid hormone regulation of calcium cycling proteins, Thyroid, 12, 453, 10.1089/105072502760143818
Kiss, 1994, Thyroid hormone-induced alterations in phospholamban protein expression. Regulatory effects on sarcoplasmic reticulum Ca2+ transport and myocardial relaxation, Circ Res, 75, 245, 10.1161/01.RES.75.2.245
Kiss, 1998, Thyroid hormone-induced alterations in phospholamban-deficient mouse hearts, Circ Res, 83, 608, 10.1161/01.RES.83.6.608
Brittsan, 1999, The effect of isoproterenol on phospholamban-deficient mouse hearts with altered thyroid conditions, J Mol Cell Cardiol, 31, 1725, 10.1006/jmcc.1999.1010
Davis, 2002, Nongenomic actions of thyroid hormone on the heart, Thyroid, 12, 459, 10.1089/105072502760143827
Sun, 2001, Thyroid hormone increases pacemaker activity in rat neonatal atrial myocytes, J Mol Cell Cardiol, 33, 811, 10.1006/jmcc.2001.1353
Drvota, 1995, Evidence for the presence of functional thyrotropin receptor in cardiac muscle, Biochem Biophys Res Commun, 211, 426, 10.1006/bbrc.1995.1831
Koshiyama, 1996, Cardiomyopathy associated with Graves’ disease, Clin Endocrinol (Oxf), 45, 111, 10.1111/j.1365-2265.1996.tb02068.x
Hoit, 1997, Effects of thyroid hormone on cardiac beta-adrenergic responsiveness in conscious baboons, Circulation, 96, 592, 10.1161/01.CIR.96.2.592
Ojamaa, 2000, Changes in adenylyl cyclase isoforms as a mechanism for thyroid hormone modulation of cardiac beta-adrenergic receptor responsiveness, Metabolism, 49, 275, 10.1016/S0026-0495(00)92262-5
Dillmann, 2002, Cellular action of thyroid hormone on the heart, Thyroid, 12, 447, 10.1089/105072502760143809
Carvalho-Bianco, 2004, Chronic cardiac-specific thyrotoxicosis increases myocardial beta-adrenergic responsiveness, Mol Endocrinol, 18, 1840, 10.1210/me.2003-0125
Ojamaa, 1996, Acute effects of thyroid hormone on vascular smooth muscle, Thyroid, 6, 505, 10.1089/thy.1996.6.505
Park, 1997, The direct vasomotor effect of thyroid hormones on rat skeletal muscle resistance arteries, Anesth Anal, 85, 734, 10.1213/00000539-199710000-00005
Fukuyama, 2003, Downregulation of vascular angiotensin II type 1 receptor by thyroid hormone, Hypertension, 41, 598, 10.1161/01.HYP.0000056524.35294.80
Diekman, 2001, Endocrine factors related to changes in total peripheral vascular resistance after treatment of thyrotoxic and hypothyroid patients, Eur J Endocrinol, 144, 339, 10.1530/eje.0.1440339
Napoli, 2001, Impact of hyperthyroidism and its correction on vascular reactivity in humans, Circulation, 104, 3076, 10.1161/hc5001.100621
Resnick, 1982, Plasma renin activity in syndromes of thyroid hormone excess and deficiency, Life Sci, 30, 585, 10.1016/0024-3205(82)90273-9